[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100461735":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":38,"centralContacts":33,"locations":42,"responsibleParty":63,"collaborators":65,"id":69,"slug":33,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":33,"eligibilityCriteria":74,"healthyVolunteers":70,"sex":75,"minAge":76,"maxAge":33,"enrollmentInfo":77,"targetDuration":33,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":33,"overallStatus":44,"whyStopped":33,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Roswell Park Cancer Institute","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A (QOL fact sheet)","EXPERIMENTAL","Patients receive study QOL intervention fact sheet during the initial consult that occurs 4 weeks prior to the standard of care surgery or SBRT. Patients have an opportunity to review the QOL fact sheet in person and discuss any questions with the treating physician(s).",[13,14],"Other: Informational Intervention","Other: Questionnaire Administration",{"label":16,"type":17,"description":18,"interventionNames":19},"Group B (usual care)","ACTIVE_COMPARATOR","Patients receive usual care during the initial consult that occurs 4 weeks prior to the standard of care surgery or SBRT.",[20,14],"Other: Best Practice",[22,29,34],{"type":6,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"Best Practice","Receive usual care",[16],[27,28],"standard of care","standard therapy",{"type":6,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"Informational Intervention","Receive QOL fact sheet",[9],null,{"type":6,"name":35,"description":36,"armGroupLabels":37,"otherNames":33},"Questionnaire Administration","Ancillary studies",[9,16],[39],{"name":40,"affiliation":5,"role":41},"Anurag K Singh","PRINCIPAL_INVESTIGATOR",[43],{"facility":5,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","Buffalo","New York","14263","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-78.87837,42.88645,{"lat":54,"lon":53},[57,62],{"name":58,"role":59,"phone":60,"phoneExt":33,"email":61},"Anurag K. Singh","CONTACT","716-845-1179","Anurag.Singh@RoswellPark.org",{"name":58,"role":41,"phone":33,"phoneExt":33,"email":33},{"type":64,"investigatorFullName":33,"investigatorTitle":33,"investigatorAffiliation":33,"oldNameTitle":33,"oldOrganization":33},"SPONSOR",[66],{"name":67,"class":68},"National Comprehensive Cancer Network","NETWORK","100461735",false,"NCT05292521","Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer","Utilizing Patient Reported Quality of Life to Inform Patient Decision Making in Early-Stage Lung Cancer","Inclusion Criteria:\n\n* Age \\>= 18 years\n* Radiographic stage I-II non-small cell lung cancer (NSCLC)\n\n  * Of note, separate tumor nodule(s) in an ipsilateral lobe different from that of the primary is considered T4 disease. However, these are treated as separate stage I or II lesions and will be eligible for this study.\n* Eligible for both surgery and SBRT\n* Able to provide informed consent in English\n* Have verbal fluency in English\n* Participant must understand the investigational nature of this study and sign an Independent Ethics Committee\u002FInstitutional Review Board approved written informed consent form prior to receiving any study related procedure\n\nExclusion Criteria:\n\n* Radiographic stage III-IV NSCLC except as noted above\n* Eligible for either only surgery or SBRT, but not both\n* Eligible for palliative-intent treatments or supportive care only.\n* Pregnant female participants.\n* Unwilling or unable to follow protocol requirements\n* Any condition which in the investigator's opinion deems the participant an unsuitable candidate\n* Cognitively impaired adults\u002Fadults with impaired decision-making capacity\n* Individuals who are not yet adults (infants, children, teenagers)\n* Prisoners","ALL","18 Years",{"count":78,"type":79},150,"ESTIMATED","INTERVENTIONAL",[82],"NA","This clinical trial studies the effect of a quality of life intervention on decision-making in patients with early-stage lung cancer who are undergoing standard of care surgery or stereotactic body radiation therapy (SBRT). Providing quality of life outcome data to patients deciding between surgery and SBRT may help decrease decision regret and increase patient satisfaction with their care.",[85,86,87,88,89,90,91,92,93],"Lung Non-Small Cell Carcinoma","Stage I Lung Cancer AJCC v8","Stage IA1 Lung Cancer AJCC v8","Stage IA2 Lung Cancer AJCC v8","Stage IA3 Lung Cancer AJCC v8","Stage IB Lung Cancer AJCC v8","Stage II Lung Cancer AJCC v8","Stage IIA Lung Cancer AJCC v8","Stage IIB Lung Cancer AJCC v8","2025-10-16",{"date":96,"type":97},"2025-10-20","ACTUAL",{"date":99,"type":97},"2023-12-21",{"date":101,"type":79},"2028-12-21",{"name":5,"class":6},1]